Jane Street’s Tema Oncology ETF CANC Stock Holding History

Jane Street’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	27,537 -61,044	-69%	-$2.31M	﹤0.01%	6265
2026 Q1	$3.25M	Buy	88,581 +56,885	+179%	+$2.07M	﹤0.01%	4201
2025 Q4	$1.1M	Buy	+31,696	New	+$1.03M	﹤0.01%	5928
2025 Q3	–	Sell	-14,104	Closed	-$349K	–	10833
2025 Q2	$349K	Buy	14,104 +5,275	+60%	+$127K	﹤0.01%	7579
2025 Q1	$213K	Buy	+8,829	New	+$222K	﹤0.01%	8362
2024 Q4	–	Sell	-44,311	Closed	-$1.26M	–	9460
2024 Q3	$1.26M	Sell	44,311 -98,880	-69%	-$2.84M	﹤0.01%	5411
2024 Q2	$3.86M	Buy	143,191 +135,172	+1,686%	+$3.65M	﹤0.01%	3376
2024 Q1	$225K	Sell	8,019 -978	-11%	-$26.6K	﹤0.01%	8008
2023 Q4	$237K	Buy	+8,997	New	+$211K	﹤0.01%	7973

Other funds holding CANC

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

PIA

Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return

OIM

Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WWM

WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

Jane Street's CANC Position: Q2 2026 in Review

Jane Street reduced its Tema Oncology ETF (CANC) stake by 69% in Q2 2026, selling an estimated $2.31M and leaving 27,537 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #6265.

Jane Street first reported a position in CANC in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.86M in Q2 2024. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

Jane Street held 27,537 shares of Tema Oncology ETF worth $1.14M as of Q2 2026.
Jane Street sold 61,044 Tema Oncology ETF shares in Q2 2026, an estimated $2.31M.
Tema Oncology ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6265 holding.
Jane Street first reported a position in Tema Oncology ETF in Q4 2023 and has held it in 9 quarters since.
Jane Street's Tema Oncology ETF position peaked at $3.86M in Q2 2024.
15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.